Evaluating skin and mucosal conditions using noninvasive imaging methods

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness of noninvasive imaging techniques in diagnosing skin and mucosal lesions, potentially improving diagnostic accuracy prior to biopsy. It utilizes various imaging modalities, including dermoscopic imaging, 3D total body photography, confocal microscopy, optical coherence tomography, and ultrasound. The collected images will be stored in an Image Repository to support clinical practice, education, and future research initiatives.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All ages
* Patients with a muco-cutaneous lesion(s) amenable to imaging by non-invasive tools
* Healthy volunteer subjects
* Ability to give informed consent or in the case of pediatric patients, assent and consent from the parent/guardian

Exclusion Criteria:

* Allergy or intolerance to ultrasound gel or mineral oil used for imaging
* Patients who are not able to comply with imaging procedure

Where it's running

• Memorial Sloan Kettering Cancer Center (All Protocol Activities)
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Manu Jain, MD — Memorial Sloan Kettering Cancer Center
• Study coordinator: Manu Jain, MD
• Email: jainm@mskcc.org
• Phone: 929-536-3604

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-resolution imaging for skin tumors using advanced optical technology

  This study is testing a new imaging system to see if it can help doctors better diagnose skin tumors without needing to do painful biopsies.

  Recruiting Apollo Medical Optics, Ltd · Berlin · NCT05068310

• Non-invasive imaging of skin lesions using advanced microscopy

  This study is testing a new imaging technique to see if it can safely and accurately capture details of skin lesions without needing a biopsy.

  Recruiting University of California, Irvine · Irvine, California · NCT01771718

• Retifanlimab after chemoradiation for anal cancer

  This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07927998

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• Graft-versus-host disease after stem cell transplant: testing LBP-MARCO with ruxolitinib

  We are testing whether combining LBP-MARCO with ruxolitinib is safe for adults with GVHD after a stem cell transplant.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07913672

• 68Ga-FAPI PET/MRI imaging to see if it can track breast cancer response to chemotherapy

  This study tests whether a new imaging scan, 68Ga-FAPI PET/MRI, can show how well invasive breast cancer responds to neoadjuvant chemotherapy in adults.

  Recruiting at 8 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT07899892

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.